Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 89bio, Aim, Astrazeneca, Heidelberg, Merck & Co., Norgine, Renexxion, Revive, Santhera, Sillajen, Sperogenix, Syndax.